You have 9 free searches left this month | for more free features.

Kirsten rat sarcoma (KRAS)

Showing 1 - 25 of 1,687

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Metastatic Colorectal Cancer (CRC) Trial in Shanghai (BI 1701963, Camptosar®)

Terminated
  • Metastatic Colorectal Cancer (CRC)
  • Shanghai, China
    Shanghai East Hospital, Tongji University China
Apr 19, 2022

AdvAdvanced Solid Tumors, Kirsten Rat Sarcoma Trial in Shanghai (GH35 Tablet)

Recruiting
  • AdvAdvanced Solid Tumors
  • Kirsten Rat Sarcoma
  • GH35 Tablet
  • Shanghai, Shanghai, China
  • +1 more
Dec 16, 2021

Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

Not yet recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +24 more
Aug 29, 2023

Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +38 more
Jan 25, 2023

Pancreatic Cancer, Circulating Tumor DNA, KRAS Mutation-Related Tumors Trial (Blood samples)

Completed
  • Pancreatic Cancer
  • +2 more
  • Blood samples
  • (no location specified)
Sep 17, 2020

Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)

Recruiting
  • Advanced Solid Tumors
  • Kirsten Rat Sarcoma (KRAS) pG12C Mutation
  • Tucson, Arizona
  • +83 more
Dec 28, 2022

Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)

Completed
  • Infiltrating Urothelial Carcinoma
  • KRAS Gene Mutation
  • Bordeaux, France
  • +16 more
Mar 4, 2021

Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

Completed
  • Colon Cancer
  • +3 more
  • Birmingham, Alabama
  • +94 more
Nov 10, 2022

Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

Not yet recruiting
  • Non-Small-Cell Lung Carcinoma
  • +2 more
  • Liquid biopsy
  • (no location specified)
Jan 24, 2023

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +4 more
  • (no location specified)
Oct 23, 2023

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

Active, not recruiting
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Aurora, Colorado
  • +196 more
Dec 22, 2022

NSCLC Trial in Worldwide (Sotorasib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Birmingham, Alabama
  • +65 more
Nov 29, 2022

Tissue Microarrays (TMAs) Construction in Lung Cancer Samples

Completed
  • Lung Cancer
    • Athens, Greece
      OCEBER
    Mar 13, 2019

    Radiomics for prEdiction of lunG cAncer biologY

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • PET/CT
    • Poitiers, France
      CHU Poitiers
    Apr 5, 2023

    Solid Tumor Trial in United States (ASP3082)

    Recruiting
    • Solid Tumor
    • Santa Monica, California
    • +10 more
    Jan 6, 2023

    Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)

    Completed
    • Metastatic Colorectal Cancer
    • Stockton, California
    • +151 more
    Sep 8, 2022

    KRAS P.G12C Trial in Worldwide (D3S-001)

    Recruiting
    • KRAS P.G12C
    • Detroit, Michigan
    • +12 more
    Jan 16, 2023

    Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

    Recruiting
    • Advanced Solid Tumors
    • GEC255 tablets
    • Chengdu, Sichuan, China
      China West Hospital
    Mar 14, 2023

    NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in United States (JAB-3312)

    Recruiting
    • Non-small Cell Lung Cancer
    • +6 more
    • Denver, Colorado
    • +3 more
    Mar 13, 2022

    HER3 Expression in Non-Small Cell Lung Cancer

    Recruiting
    • Non-small Cell Lung Cancer
    • Archival tissue specimen and immunohistochemistry staining
    • Miami, Florida
    • +1 more
    Mar 14, 2023

    NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Aug 17, 2023

    NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in Beijing, Henan (JAB-3312)

    Recruiting
    • Non-small Cell Lung Cancer
    • +6 more
    • Beijing, Beijing, China
    • +4 more
    Dec 28, 2021

    Tumors, Advanced Solid Tumors, NSCLC Trial in France, United States (JNJ-74699157)

    Completed
    • Neoplasms
    • +3 more
    • Sarasota, Florida
    • +6 more
    Nov 5, 2020